Author

N. Boyer

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Cell Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Organism:mouse· 1

Frequent Co-Authors

K. Biswas· 2 shared A. Hill· 1 shared A. Peier· 1 shared A. Sadruddin· 1 shared A. Stoeck· 1 shared A. W. Partridge· 1 shared B. Bhatt· 1 shared B. Henry· 1 shared

Activity by Year

2021-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

K. Biswas

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Oncostatin M is a Master Regulator of an Inflammatory Network in Dnmt3a-Mutant Hematopoietic Stem Cells

L. S. Schwartz, K. A. Young, T. M. Stearns, N. Boyer, K. D. Mujica, J. J. Trowbridge

This study identifies Oncostatin M (OSM) as a master regulator of an inflammatory network in Dnmt3a-mutant hematopoietic stem cells, showing its role in age-associated clonal hematopoiesis.

bioRxiv · Jul 12, 2023 · PreprintCell Biology

Development of a high-throughput barrier function assay using primary human gut organoids

C. W. Wright, N. Li, L. Shaffer, A. Hill, N. Boyer, S. Alves, S. Venkat, K. Biswas, L. A. Lieberman, S. Mohammadi

The paper develops a high-throughput assay using primary human gut organoids to assess barrier function and response to TNF-α, showing dose-dependent rescue by antagonists.

bioRxiv · Dec 16, 2022 · PreprintImmunology

Discovery of cell active macrocyclic peptides with on-target inhibition of KRAS signaling

S. Lim, N. Boyer, N. Boo, C. Huang, G. Venkatachalam, Y.-C. A. Juang, M. Garrigou, K. Kaan, K. M. Peh, A. Sadruddin, P. Gopal, R. Duggal, T. Y. Yuen, S. Ng, S. Kannan, , A. W. Partridge

This paper identifies macrocyclic peptides that inhibit KRAS signaling by binding to its hydrophobic pocket, showing on-target activity and improved proteolytic stability.

bioRxiv · Sep 11, 2021Biochemistry